Of patients with ovarian cancer, 14.5–24% carried germ-line mutations in cancer-associated genes [114,115,116], including BRCA1/2 mutations that were observed in 13.3–15.3% [117,118,119]. The gene discussed is BRCA1; the disease is cancer.